900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Polymyxin b sulfate + trimethoprim sulfate	Product containing polymyxin B and trimethoprim (medicinal product)
Polyomavirus group	Genus Polyomavirus (organism)
Polyomavirus hominis	Genus Polyomavirus (organism)
polysomatöst missbildat foster	Polysomia (disorder)
polyvinylalkohol 1,4 %, ögondroppar	Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug)
polyvinylalkohol 1,4 %, ögondroppar för engångsbruk	Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug)
havsbraxen eller svartfisk, livsmedel	Pomfret (substance)
Poor concentration	Poor concentration
Poor concentration	Poor concentration
Poor concentration	Poor concentration
Poor labor contractions	Uterine inertia
långsam metaboliserare på grund av cytokrom P450, variant CYP2C19	Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding)
långsam metaboliserare på grund av cytokrom P450, variant CYP2C9	Cytochrome P450 family 2 subfamily C member 9 poor metabolizer (finding)
långsam metaboliserare på grund av cytokrom P450, variant CYP2D6	Cytochrome P450 family 2 subfamily D member 6 poor metabolizer (finding)
porcin faktor VIII, 700 IE, pulver och vätska till injektionsvätska, lösning, flaska	Product containing only porcine factor VIII in parenteral dose form (medicinal product form)
Porphyromonas assacharolytica	Porphyromonas asaccharolyticus
Porphyromonas endodontalis	Porphyromonas endodontalis
Porpoise distemper virus	Cetacean morbillivirus (organism)
Portable electroencephalogram awake and asleep with hyperventilation and/or photic stimulation	Portable electroencephalogram awake and asleep with stimulation
Portable electroencephalogram awake and drowsy with hyperventilation and/or photic stimulation	Portable electroencephalogram awake and drowsy with stimulation
manlig urinrörsmynnings läge	Position of male external urethral orifice (observable entity)
PET-undersökning av myokardiet i vila med ^81^Rb	Positron emission tomography myocardial rest imaging using rubidium-82 (procedure)
PET-undersökning av myokardiet under belastning med ^81^Rb	Positron emission tomography myocardial stress imaging using rubidium-82 (procedure)
PET-undersökning med datortomografi av myokardiet i vila med ^81^Rb	Positron emission tomography with computed tomography myocardial rest imaging using rubidium-82 (procedure)
PET-undersökning med datortomografi av myokardiet under belastning med ^81^Rb	Positron emission tomography with computed tomography myocardial stress imaging using rubidium-82 (procedure)
möjlig graviditet	Possible pregnancy
lymfoproliferativ sjukdom efter transplantation	Post-transplantation lymphoproliferation (morphologic abnormality)
posttranslationell genetisk RNA-modifiering	Post-transcriptional genetic ribonucleic acid processing (finding)
Postcoital bleeding	Postcoital bleeding
Posterior cervical cord injury without bony injury, C5-7	Posterior cervical spinal cord injury without spinal bone injury, C5-7 (disorder)
Posterior cervical cord injury, without bony injury, C1-4	Posterior cervical spinal cord injury, without spinal bone injury, C1-4 (disorder)
Posterior ligament of iris	Trabecular meshwork structure
postnatal anti-D-profylax avböjd	Administration of RhD immune globulin declined
postoperativ cellulit i operationssår	Postoperative wound cellulitis
postoperativa åtgärder	Postoperative procedure (procedure)
Postoperative pulmonary edema	Postoperative pulmonary edema
Posttraumatic wound infection, NEC	Post-traumatic wound infection
Postural proteinuria	Orthostatic proteinuria (finding)
kalium 6,5 millimol, brustablett	Potassium only product in oral dose form
kaliumallergi	Propensity to adverse reaction to potassium (finding)
kaliumvätekarbonat 1,39 g + citronsyra 1,14 g, löslig tablett	Citric acid and potassium bicarbonate only product in oral dose form
kaliumklorid 10 %, injektionsvätska, lösning, ampull	Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
kaliumklorid 10 milliekvivalenter, tablett med modifierad frisättning	Product containing only potassium chloride in oral dose form (medicinal product form)
kaliumklorid 10 milliekvivalenter, depåtablett	Product containing only potassium chloride in oral dose form (medicinal product form)
dextros 4 % + kaliumklorid 10 mmol , infusionsvätska, lösning, påse 500 ml	Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection
dextros 5 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml	Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug)
glukos 5 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml	Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection
natriumklorid 0,9 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml	Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
Potassium chloride 1500mg	Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug)
Potassium chloride 15meq	Potassium chloride only product
kaliumklorid 15 milliekvivalenter per förpackning	Potassium chloride only product
kaliumklorid 1 000 mg/5 ml, lösning	Potassium chloride only product
kaliumklorid 1 000 mg/ml, lösning	Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug)
kaliumklorid 20 %, injektionsvätska, lösning, ampull	Potassium chloride 200 mg/mL solution for injection
kaliumklorid 20 %, lösning	Potassium chloride only product
kaliumklorid 20 milliekvivalenter, pulver	Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug)
Potassium chloride 20meq/15m solution	Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug)
kaliumklorid 20 milliekvivalenter/15 ml, lösning	Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug)
kaliumklorid 20 milliekvivalenter per förpackning	Potassium chloride only product
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml	Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 500 ml	Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection
glukos 5 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml	Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection
glukos 5 % + kaliumklorid 20 millimol, infusionsvätska, lösning, påse 500 ml	Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection
natriumklorid 0,9 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml	Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
natriumklorid 0,9 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 500 ml	Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1 000 ml	Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection
glukos 5 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1 000 ml	Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection
natriumklorid 0,9 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1000 ml	Product containing precisely potassium chloride 2 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml	Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection
glukos 5 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml	Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection
natriumklorid 0,9 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml	Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
kaliumklorid 7,5 %, sirap	Product containing only potassium chloride in oral dose form (medicinal product form)
injektionskoncentrat kaliumklorid 15 %, lösning, ampull	Product containing only potassium chloride in parenteral dose form (medicinal product form)
kaliumcitrat 12 g/10 ml koncentrerad blandning	Product containing only potassium citrate in oral dose form (medicinal product form)
kaliumcitrat 12 g/10 ml, oral lösning	Product containing only potassium citrate in oral dose form (medicinal product form)
kaliumcitrat 3 g/dospåse, granulat	Product containing only potassium citrate in oral dose form (medicinal product form)
biverkningar av kaliumklorazepat	Adverse reaction to clorazepate
kaliumglukonat 20 milliekvivalenter/15 ml, elixir	Product containing precisely potassium gluconate 312 milligram/1 milliliter conventional release oral solution (clinical drug)
kaliumpermanganat 400 mg, tablett till kutan lösning	Product containing permanganic acid in cutaneous dose form (medicinal product form)
kaliumpermanganat 400 mg, tablett till lösning	Product containing permanganic acid in cutaneous dose form (medicinal product form)
kaliumfosfat 2 mmol/ml, injektionsvätska, lösning, ampull 10 ml	Product containing precisely monobasic potassium phosphate 136 milligram/1 milliliter conventional release solution for injection (clinical drug)
kaliumtillskott	Potassium and/or potassium compound
potatis, livsmedel	Potato (substance)
Potexvirus group	Genus Potexvirus (organism)
Potts fraktur	Bimalleolar fracture of ankle
Pouched mammal	Infraclass Metatheria (organism)
povidon 5 %, ögondroppar	Povidone 50 mg/mL eye solution
povidon 5 %, ögondroppar för engångsbruk	Povidone 50 mg/mL eye solution
joderad povidon 10 %, preparat för pensling	Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
joderad povidon 10 %, svamp för lokalt bruk	Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
joderad povidon 10 %, vaginalgel	Iodine (as povidone iodine) 100 mg/g vaginal gel
joderad povidon 20 %, svamp för lokalt bruk	Povidone iodine only product in cutaneous dose form
joderad povidon 200 mg, suppositorium	Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug)
joderad povidon 5 %, svamp för lokalt bruk	Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
pulver till suspension	Powder (basic dose form)
Powered wheelchair	Motorized wheelchair device (physical object)
Poxvirus group	Family Poxviridae (organism)
Pramipexole dihydrochloride 125micrograms tablet	Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug)
Pramipexole dihydrochloride 1mg tablet	Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet
Pramipexole dihydrochloride 250micrograms tablet	Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet
pramlintid 1 mg/ml, injektionsvätska, lösning, förfylld penna	Pramlintide only product

Start Previous Page 66 of 107 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)